Efficacy of oxetanocin G against herpes simplex virus type 2 and murine cytomegalovirus infections in mice.
Nishiyama
Y
Y
Laboratory of Virology, Nagoya University School of Medicine, Japan.
Yamamoto
N
N
Yamada
Y
Y
Fujioka
H
H
Shimada
N
N
Takahashi
K
K
D000212:Acyclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000382:microbiology; D004195:Disease Models, Animal; D015774:Ganciclovir; D006147:Guanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006561:Herpes Simplex / Q000188:drug therapy*; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D011355:Prodrugs / Q000627:therapeutic use
D000998:Antiviral Agents; D011355:Prodrugs; C057479:oxetanocin G; C060650:2-aminooxetanocin A; D006147:Guanine; D000225:Adenine; D015774:Ganciclovir; D000212:Acyclovir